Avanos Medical (AVNS)

Avanos Medical (AVNS) Income Statement


Avanos Medical Income Statement

Last quarter (Q1 2023), Avanos Medical's total revenue was $191.70M, a decrease of -2.89% from the same quarter last year. In Q1, Avanos Medical's net income was $-500.00K. See Avanos Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 814.30M$ 820.00M$ 744.60M$ 714.80M$ 697.60M$ 652.30M
Cost of Revenue
$ 367.00M$ -370.00M$ 380.30M$ 341.50M$ 295.40M$ 261.40M
Gross Profit
$ 447.30M$ 450.00M$ 364.30M$ 373.30M$ 402.20M$ 390.90M
Operating Expense
$ 379.90M$ 376.00M$ 355.40M$ 419.40M$ 457.90M$ 390.40M
Operating Income
$ 67.40M$ 74.00M$ 8.90M$ -46.10M$ -55.70M$ 500.00K
Net Non Operating Interest Income Expense
$ -10.50M$ -8.80M$ -3.10M$ -14.40M$ -8.30M$ -18.60M
Other Income Expense
-$ -7.80M----
Pretax Income
$ 56.90M$ 65.20M$ 5.80M$ -60.50M$ -64.00M$ -18.10M
Tax Provision
$ 12.70M$ 14.70M$ 600.00K$ -33.30M$ -18.10M$ -9.60M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 44.20M$ 50.50M$ 5.20M$ -27.20M$ -45.90M$ 57.50M
Basic EPS
$ 0.95$ 1.08$ 0.11$ -0.57$ -0.96$ 1.22
Diluted EPS
$ 0.94$ 1.07$ 0.11$ -0.57$ -0.96$ 1.22
Basic Average Shares
$ 93.80M-$ 48.10M$ 47.80M$ 47.60M$ 47.20M
Diluted Average Shares
$ 94.60M-$ 48.60M$ 47.80M$ 47.60M$ 47.20M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
--$ 1.15$ 0.79$ 1.07$ 0.82
Rent Expense Supplemental
Total Expenses
$ 746.90M$ 6.00M$ 735.70M$ 760.90M$ 753.30M$ 651.80M
Net Income From Continuing And Discontinued Operation
$ 44.20M$ 50.50M$ 5.20M$ -27.20M$ -45.90M$ 57.50M
Normalized Income
$ 27.10M-$ 5.20M$ -27.20M$ -45.90M$ -8.50M
Interest Expense
$ 5.70M-$ 3.30M$ 15.60M$ 15.00M$ 26.40M
$ 67.90M$ 74.00M$ 9.10M$ -44.90M$ -49.00M$ 8.30M
$ 116.60M$ 121.70M$ 47.40M$ -2.00M$ -12.10M$ 41.80M
Currency in USD

Avanos Medical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis